MedTrace Logo

The Second-Generation MCCG for Upper Gastrointestinal Tract.

NCT03977935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-10-27

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the clinical application of the second-generation MCCG with higher image resolution and frame rate for upper gastrointestinal tract compared with the first-generation.

Conditions

  • Capsule Endoscopy

Interventions

DEVICE

the second-generation MCCG

Patients in the experimental group swallowed the second-generation MCCG (Ankon Navicam-2).

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2019-07-18
Completion
2019-07-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977935 on ClinicalTrials.gov